The Oncology Institute (TOI)
(Delayed Data from NSDQ)
$0.47 USD
-0.01 (-2.47%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $0.46 -0.01 (-1.10%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum D VGM
Price, Consensus and EPS Surprise
TOI 0.47 -0.01(-2.47%)
Will TOI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TOI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TOI
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
TOI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround
Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus
Elevance Health (ELV) Q3 Earnings Top Estimates
Other News for TOI
12 Health Care Stocks Moving In Tuesday's After-Market Session
The Oncology Institute to Participate at Upcoming Investor Conferences
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
The Oncology Institute, Inc. (TOI) Q1 2024 Earnings Call Transcript
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session